Time to face the proofs: the BCG Moreau vaccine promotes superior inflammatory cytokine profile in vitro when compared with Russia, Pasteur, and Danish strains

Silva, Andreon Santos Machado da; Albuquerque, Lawrence Henrique Paz; Ponte, Carlos Germano Garrido de; Almeida, Matheus Rogério de; Faria, Sandra Elizabete Ribeiro de; Ribeiro, Mariana da Silva; Pereira, Evelyn Nunes Goulart da Silva; Antas, Paulo Renato Zuquim.
Artículo en Inglés | ARCA | ID: arc-50853

Documentos relacionados

  1. Time to face the proofs: the BCG Moreau vaccine promotes superior inflammatory cytokine profile <i>in vitro</i> when compared with Russia, Pasteur, and Danish strains.
  2. Instrumental goals shape EU citizens' attitudes to the Russia-Ukraine war over time.
  3. Axenic in vitro cultivation of 19 peat moss (Sphagnum L.) species as a resource for basic biology, biotechnology, and paludiculture.
  4. Diversity of Chrysophycean Stomatocysts in the Steppe Zone of the South Urals.
  5. [International and Russian mechanisms for integrating innovations and experience to optimize the nutrition of the population].
  6. [Historical study of medical geography in Russia].
  7. First insight into the whole-genome sequence variations in Mycobacterium bovis BCG-1 (Russia) vaccine seed lots and their progeny clinical isolates from children with BCG-induced adverse events.
  8. Efficiency of renewable energy plants in Russia.
  9. Cultural and enzymatic activity studies of a pathogenic wood-decaying fungus Fomitiporia hippophaeicola (Hymenochaetales, Basidiomycota), recollected in the Eastern Caucasus.
  10. [Applying robust management approaches to transit to value-based healthcare].